Healthtech Startups

Theranica develops prescription digital therapeutics for pain management, including Nerivio, a wearable device that uses remote electrical neuromodulation of upper arm nerves to trigger the body's Conditioned Pain Modulation mechanism. Its products target neurological pain conditions such as migraine and offer a drug-free alternative for patients.

2 investors

TTP develops the Thermo Trauma Port, a novel patient transfer device for the trauma care pathway, created with a consortium including East Anglian Air Ambulance, University Hospital of Birmingham and the University of Portsmouth. The device targets pre-hospital and in-hospital emergency and critical care settings, with clinical usability testing conducted through the NIHR.

2 investors

Therorna develops circular RNA-based therapeutic candidates and preventive medicines for diseases with unmet clinical needs. The company was founded in 2021 by domestic experts and overseas-educated PhDs to advance circular RNA technology in drug discovery and therapy.

2 investors

Celerion provides clinical pharmacology and bioanalytical services to support pharmaceutical and biotechnology companies in early-phase drug development and regulatory submissions. The company operates clinical research units and bioanalytical laboratories across North America and Europe.

2 investors

Thrive Mobile provides affordable wireless plans through the Lifeline program, powered by SafetyNet Wireless, with plans starting at $0/month and integrated health resources for low-income users. The service includes access to a mobile app and Thrive Assistants support for scheduling and connection to local resources.

2 investors

Thryve provides a platform that enables partners to improve patient engagement, preventive care, and clinical research through real-world health insights and insurance innovation.

2 investors

Tilly provides a platform that connects autism-care and special education professionals with children in need of support. The software enables collaboration and communication between providers, families, and educators to coordinate personalized care in home and classroom settings.

2 investors

Time Study offers an enterprise platform for conducting time studies, centralizing time data management, validation, and reporting so finance teams can produce audit-ready, defensible reports without adding administrative burden. It serves complex organizations such as health systems in the United States.

2 investors

TimeSmart.AI provides a platform designed for healthcare organizations to automate physician contract management, administrative workflows, and time tracking. The solution eliminates manual processes around medical directorships and on-call coverage agreements while ensuring compliance with healthcare regulations.

2 investors

TimeTrace Labs builds a "measurement layer" for healthcare, applying mathematics, statistical inference, and deep learning to multimodal physiological time-series to detect disease earlier and resolve drug effects and individual physiology at higher precision. It serves pharma, biotech, wearable makers, health systems, and CROs, with its methods applied across 7M+ individuals and 30+ clinical conditions.

2 investors

Tivara provides AI agents that automate inbound patient phone calls for healthcare practices, handling scheduling, prescription refills, intake, and after-hours triage while integrating with existing EMR and practice management systems. The platform reduces operational costs and improves patient access by resolving routine requests autonomously.

2 investors

TJM Labs builds AI agents that automate pharmacy operational tasks such as prescription intake, data entry, refills, prior authorization, and patient communication, working across pharmacies' existing systems with pharmacist oversight. It serves pharmacy teams and is used across 450+ pharmacies.

2 investors

Sunstone uses AI to analyze health system claims data to identify patients with undiagnosed or misdiagnosed genetic conditions like autism and epilepsy, providing precision care recommendations to health plans and employers to reduce costs and improve patient outcomes.

2 investors

Toi Labs manufactures an AI-enabled toilet seat system that monitors and reports on waste patterns and health indicators for senior living communities and consumers. The product automates health observation tracking for care facilities and provides wellness insights to individual users.

2 investors

Tombot creates animatronic robotic pets designed to provide companionship and therapeutic benefits for people who cannot care for live animals, with initial focus on treating behavioral and psychological symptoms in older adults with dementia. The company aims to achieve FDA approval as a medical device while expanding to serve the broader market of 4 billion people globally who do not keep live animals as pets.

2 investors

ToothFairy is a dental app that pairs patients with real dentists via secure video calls for same-day emergency advice, virtual exams, and a 24/7 helpline, and offers cosmetic treatments such as clear aligners and teeth whitening through dentist prescriptions. It also sells its service to businesses and insurers as an employee dental benefit, with a stated focus on the UK/Europe.

2 investors

Abbott's Lingo Glucose System is a continuous glucose monitoring device for non-insulin users aged 18+, designed to track glucose levels and support metabolic health decisions.

2 investors

Topo Therapeutics is a drug discovery company developing treatments targeting ion channels and transmembrane proteins for conditions such as pain, epilepsy, and CNS, pulmonary, and renal diseases. It is built around scientific advisors and leadership with expertise in ion channel biology and biophysics.

2 investors

Toro Bio develops automated systems for cell and gene therapy production at point of care, enabling personalized cancer therapies. The company focuses on streamlining process development and manufacturing for therapeutic applications.

2 investors

TORTUS develops health technology with a focus on clinical evidence and sustainable growth. The company prioritizes rigorous trials, scientific validation, and demonstrable value delivery to clinicians and patients over rapid, disruption-focused approaches.

2 investors

Tr1X is a biopharmaceutical company developing cell and gene therapies to cure autoimmune and inflammatory diseases with high unmet medical need. The company translates scientific discoveries in immune regulation and regenerative medicine into novel patient therapies.

2 investors

Trace Biosciences develops technology to make nerves visible in real time during surgical procedures, enabling surgeons to better identify and preserve nerve structures. The company targets operating rooms with fluorescent imaging agents and related surgical visualization tools.

2 investors

Trace Orthopedics is developing a device and technique (the Trace Method) to repair partially torn tendons back to bone through a needle inserted through the skin, avoiding open or arthroscopic surgery and general anesthesia. The percutaneous tendon repair product is aimed at surgeons treating tendon injuries, in the medical device industry.

2 investors

Trace3 provides cloud consulting and delivery services, including cloud strategy across Azure, AWS, and GCP, application modernization, cloud assessment and cost management, DevOps/CI-CD implementation, migration, and cloud security. It serves enterprise businesses looking to build, migrate, and optimize public and hybrid cloud environments.

2 investors